Top Markets
Coin of the day
AIxCrypto Holdings, Inc. AIxCrypto Holdings, Inc.

AIxCrypto Holdings, Inc.

AIXC
Rang in aandelen #27458
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company... AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
Aandeelprijs
$1.62
Laatst gesynchroniseerd: 2026-08-19
Marktkapitalisatie
$32.77M
Verandering (1 dag)
22.67%
Verandering (1 jaar)
-13.87%
Land
US
Handel AIxCrypto Holdings, Inc. (AIXC)

Categorie

Koersgeschiedenis voor AIxCrypto Holdings, Inc. (AIXC)
Hoogste slotkoers: $0.90 op 2026-08-01

Laagste slotkoers: $589.38K op 2015-06-01
Koersgeschiedenis van AIxCrypto Holdings, Inc. van 2015 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -22.79%
2025 -39.97%
2024 -86.58%
2023 -55.55%
2022 -87.61%
2021 -67.06%
2020 -20.10%
2019 -75.33%
2018 -77.35%
2017 -88.49%
2016 37.25%
2015 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$61.63 67.11%
US
$51.85 75.00%
SE
$197.14 46.35%
FR
$119.62 69.92%
US
$62.93 2.96%
IT